Tandem Diabetes Care. has been granted a patent for a portable infusion pump system designed for delivering medicaments, such as insulin. The system features a remote control device with a touchscreen interface that allows users to input bolus calculations and control the infusion pump remotely. GlobalData’s report on Tandem Diabetes Care gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Tandem Diabetes Care, Wearable drug delivery devices was a key innovation area identified from patents. Tandem Diabetes Care's grant share as of June 2024 was 47%. Grant share is based on the ratio of number of grants to total number of patents.
Portable infusion pump system for medicament delivery
The patent US12042627B2 describes a portable infusion pump system designed to facilitate the delivery of medicaments to users through a user-friendly interface. The system comprises a portable infusion pump equipped with a reservoir for medicament storage and a pumping mechanism for delivery. A remote control device, which can be a cell phone, is integrated into the system, featuring a touchscreen display and a processor. This device allows users to interactively set up bolus delivery through a dedicated bolus setup page. Users can input numerical values for bolus calculations via touch-selectable objects, which include options for food and blood glucose levels. The system calculates the bolus based on user input and displays the result, enabling the pump to deliver the calculated dosage.
Additionally, the remote control device is designed to enhance user experience by providing features such as a virtual numeric keypad for input, a view calculation object to explain how the bolus was determined, and a stop insulin function that allows users to halt delivery if needed. The interface also includes discrete bolus status indicators that visually represent the delivery process, changing appearance to indicate ongoing delivery. The system is engineered to update the bolus calculation dynamically as users input new values, ensuring accurate and timely medicament delivery. Overall, this patent outlines a comprehensive and interactive approach to managing infusion therapy, emphasizing user control and real-time feedback.
To know more about GlobalData’s detailed insights on Tandem Diabetes Care, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
